Sun Pharma halts eye-care drug production in India after regulator cited quality failures
read at BioSpace ↗RegulatoryNegative
Sun Pharma has stopped manufacturing eye-care medicines at its Assam facility after Indian regulators identified failures in the company's quality management system.
The company previously recalled 11 ophthalmology products in July and, during its earnings call, said it was voluntarily initiating a temporary halt to production.
Regulators are reviewing Sun Pharma's compliance report, and the firm says remedial actions are underway to address the identified issues.
source
This writeup was produced by pharmadog from original reporting by BioSpace.
Original headline: “Sun Pharma stops eye-care drug production at Indian plant amid quality issues”
read at BioSpace ↗550 words · retrieved 2h ago
comments(0)
5-min edit window · permanent after that